Almoosa Health Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	184.82	94.42	98.15	51.02	62.42	104.77
Depreciation & Amortization	81.73	81.73	64.76	56.94	28.49	23.36
Other Amortization	2.62	2.62	3.53	2.65	1.46	1.58
Loss (Gain) From Sale of Assets	-0.11	-0.11	-0.33	-0.03	0.07	-0
Asset Writedown & Restructuring Costs	-	-	-	0.01	0.01	0.55
Loss (Gain) on Equity Investments	-1.19	-1.19	-	-	-	-
Provision & Write-off of Bad Debts	4.41	4.41	3.93	-0.17	1.22	0.15
Other Operating Activities	-125.72	25.38	10.36	14.93	12.08	-2
Change in Accounts Receivable	-42.3	-42.3	-166.81	-66.22	-10.71	-28.82
Change in Inventory	-8.81	-8.81	-9.29	-0.16	-7.77	-6.47
Change in Accounts Payable	42.92	42.92	3.15	-49.76	75.25	80.92
Change in Other Net Operating Assets	-15.38	-15.38	32.62	-20.19	35.21	-24.13
Operating Cash Flow	122.98	183.68	40.07	-10.97	197.72	149.92
Operating Cash Flow Growth	-	358.41%	-	-	31.88%	-
Capital Expenditures	-240.34	-240.34	-383.19	-307.18	-318.47	-436.81
Sale of Property, Plant & Equipment	1.36	1.36	23.07	0.03	0.02	0.04
Sale (Purchase) of Intangibles	-6.33	-6.33	-2.16	-2.89	-0.31	-1.12
Sale (Purchase) of Real Estate	-16.93	-16.93	-92.1	-	-	-
Investment in Securities	-	-	-	-	3.28	-
Investing Cash Flow	-496.83	-262.23	-454.39	-310.04	-315.49	-437.89
Long-Term Debt Issued	-	305.59	622.91	285.67	148.91	290.53
Short-Term Debt Repaid	-	-	-	-	-	-1
Long-Term Debt Repaid	-	-190.67	-208	-7.54	-7.54	-0.75
Total Debt Repaid	-190.67	-190.67	-208	-7.54	-7.54	-1.75
Net Debt Issued (Repaid)	114.92	114.92	414.92	278.13	141.38	288.78
Issuance of Common Stock	-	-	-	-	-	5
Common Dividends Paid	-14.01	-14.01	-	-	-15.66	-
Financing Cash Flow	430.52	100.92	414.92	278.13	125.71	293.78
Net Cash Flow	56.66	22.36	0.6	-42.88	7.94	5.81
Free Cash Flow	-117.36	-56.66	-343.12	-318.15	-120.76	-286.89
Free Cash Flow Margin	-8.94%	-4.71%	-35.05%	-38.99%	-17.21%	-45.61%
Free Cash Flow Per Share	-2.65	-1.62	-9.80	-9.09	-1207.55	-
Cash Interest Paid	78.55	78.55	24.02	10	1.14	1.44
Levered Free Cash Flow	-	-112.73	-369.73	-359.89	-122.63	-
Unlevered Free Cash Flow	-	-63.42	-357.82	-351.6	-121.7	-
Change in Working Capital	-23.57	-23.57	-140.33	-136.33	91.98	21.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.